ChronVac-C: Completed Phase IIb enrollment

ChronTech disclosed in its interim results for the first 9 months of 2012, that it completed enrollment of 32 patients in an open-label, Swedish Phase IIb trial evaluating 2 doses of 500 µg intramuscu...